182 related articles for article (PubMed ID: 19501395)
21. The use of folate-PEG-grafted-hybranched-PEI nonviral vector for the inhibition of glioma growth in the rat.
Liang B; He ML; Chan CY; Chen YC; Li XP; Li Y; Zheng D; Lin MC; Kung HF; Shuai XT; Peng Y
Biomaterials; 2009 Aug; 30(23-24):4014-20. PubMed ID: 19427690
[TBL] [Abstract][Full Text] [Related]
22. [Transplantation and magnetic resonance imaging of transplantable human glioma tissue in the brain of nude mice].
Li RJ; Diao Y; Huang Q; Shen JK; Lan Q
Ai Zheng; 2007 Sep; 26(9):937-41. PubMed ID: 17927848
[TBL] [Abstract][Full Text] [Related]
23. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
[TBL] [Abstract][Full Text] [Related]
24. Synergistic anti-tumor activity of paclitaxel-incorporated conjugated linoleic acid-coupled poloxamer thermosensitive hydrogel in vitro and in vivo.
Guo DD; Xu CX; Quan JS; Song CK; Jin H; Kim DD; Choi YJ; Cho MH; Cho CS
Biomaterials; 2009 Sep; 30(27):4777-85. PubMed ID: 19524293
[TBL] [Abstract][Full Text] [Related]
25. Targeting CD24 for treatment of ovarian cancer by short hairpin RNA.
Su D; Deng H; Zhao X; Zhang X; Chen L; Chen X; Li Z; Bai Y; Wang Y; Zhong Q; Yi T; Qian Z; Wei Y
Cytotherapy; 2009; 11(5):642-52. PubMed ID: 19593703
[TBL] [Abstract][Full Text] [Related]
26. Controlling the degradation of covalently cross-linked carboxymethyl chitosan utilizing bimodal molecular weight distribution.
Lu G; Sheng B; Wang G; Wei Y; Gong Y; Zhang X; Zhang L
J Biomater Appl; 2009 Mar; 23(5):435-51. PubMed ID: 18697877
[TBL] [Abstract][Full Text] [Related]
27. A chitosan-dipotassium orthophosphate hydrogel for the delivery of Doxorubicin in the treatment of osteosarcoma.
Ta HT; Dass CR; Larson I; Choong PF; Dunstan DE
Biomaterials; 2009 Jul; 30(21):3605-13. PubMed ID: 19345993
[TBL] [Abstract][Full Text] [Related]
28. Chitosan film as rhBMP2 carrier: delivery properties for bone tissue application.
Abarrategi A; Civantos A; Ramos V; Sanz Casado JV; López-Lacomba JL
Biomacromolecules; 2008 Feb; 9(2):711-8. PubMed ID: 18163540
[TBL] [Abstract][Full Text] [Related]
29. Effect of chitosan particles and dexamethasone on human bone marrow stromal cell osteogenesis and angiogenic factor secretion.
Guzmán-Morales J; El-Gabalawy H; Pham MH; Tran-Khanh N; McKee MD; Wu W; Centola M; Hoemann CD
Bone; 2009 Oct; 45(4):617-26. PubMed ID: 19540373
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of high molecular weight FGF-2 forms inhibits glioma growth by acting on cell-cycle progression and protein translation.
Lemiere S; Azar R; Belloc F; Gürsel D; Pyronnet S; Bikfalvi A; Auguste P
Exp Cell Res; 2008 Dec; 314(20):3701-11. PubMed ID: 18930044
[TBL] [Abstract][Full Text] [Related]
31. Polyglycolic acid/chitosan glue and apoptosis of endometriotic cells.
Wang YC; Fu RH; Hsieh HJ; Chao HT; Kao SH
Fertil Steril; 2005 Jul; 84(1):75-81. PubMed ID: 16009160
[TBL] [Abstract][Full Text] [Related]
32. [Antiglioma activity of endothelial progenitor cells transduced with HSV-TK via inhibiting angiogenesis in vitro and in vivo].
Zhang JX; Zhao P; Li R; Shi L; Cheng ZH; You YP; Fu Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr; 26(2):170-4. PubMed ID: 19350509
[TBL] [Abstract][Full Text] [Related]
33. Cytocompatibility and hemocompatibility of a novel chitosan-alginate gel system.
Notara M; Scotchford CA; Grant DM; Weston N; Roberts GA
J Biomed Mater Res A; 2009 Jun; 89(4):854-64. PubMed ID: 18465818
[TBL] [Abstract][Full Text] [Related]
34. [Effect of all-trans-retinoic acid on C6 glioma cell proliferation and differentiation].
Tang K; Cao L; Fan SQ; Wu MH; Huang H; Zhou YH; Zhou M; Tang YL; Wang R; Zeng F; Liao P; Li XL; Li GY
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 33(10):892-7. PubMed ID: 19001730
[TBL] [Abstract][Full Text] [Related]
35. Branched chitosans II: Effects of branching on degradation, protein adsorption and cell growth properties.
Aggarwal D; Matthew HW
Acta Biomater; 2009 Jun; 5(5):1575-81. PubMed ID: 19231304
[TBL] [Abstract][Full Text] [Related]
36. In vivo performance of implantable biodegradable preparations delivering Paclitaxel and Etanidazole for the treatment of glioma.
Kumar Naraharisetti P; Yung Sheng Ong B; Wei Xie J; Kam Yiu Lee T; Wang CH; Sahinidis NV
Biomaterials; 2007 Feb; 28(5):886-94. PubMed ID: 17067667
[TBL] [Abstract][Full Text] [Related]
37. Ellagic acid induces novel and atypical PKC isoforms and promotes caspase-3 dependent apoptosis by blocking energy metabolism.
Mishra S; Vinayak M
Nutr Cancer; 2014; 66(4):675-81. PubMed ID: 24571130
[TBL] [Abstract][Full Text] [Related]
38. The inhibitory effect of suramin on telomerase activity and spheroid growth of C6 glioma cells.
Erguven M; Akev N; Ozdemir A; Karabulut E; Bilir A
Med Sci Monit; 2008 Aug; 14(8):BR165-73. PubMed ID: 18667993
[TBL] [Abstract][Full Text] [Related]
39. Inhibitive effect of artemether on tumor growth and angiogenesis in the rat C6 orthotopic brain gliomas model.
Wu ZP; Gao CW; Wu YG; Zhu QS; Yan Chen ; Xin Liu ; Chuen Liu
Integr Cancer Ther; 2009 Mar; 8(1):88-92. PubMed ID: 19174507
[TBL] [Abstract][Full Text] [Related]
40. Ellagic acid-loaded, tween 80-coated, chitosan nanoparticles as a promising therapeutic approach against breast cancer: In-vitro and in-vivo study.
Kaur H; Ghosh S; Kumar P; Basu B; Nagpal K
Life Sci; 2021 Nov; 284():119927. PubMed ID: 34492262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
